Apixaban to Prevent Venous Thromboembolism in Ambulatory Lung Cancer Patients Undergoing Systemic Anticancer Treatment
NCT07160686
·
clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
1456
Enrollment
OTHER
Sponsor class
Conditions
Thromboprophylaxis
Interventions
DRUG:
Apixaban
OTHER:
Placebo
Sponsor
University of Birmingham